In May 2024, Apnimed completed the enrollment in the Phase III LunAIRo study for AD109, a potential first oral nighttime treatment for obstructive sleep apnea (OSA)
In laboratory workflows, this two-component blend is often positioned for mechanistic studies involving endocrine signaling regulation, receptor activation patterns, and hormone-associated biomarker responses, where researchers prioritize controlled conditions, stability, and reproducibility across experimental models
RECOMMENDED USE: For best results use after bath, lightly towel dry skin and apply the lotion while the skin is still damp to lock-in moisture
Reduces cell damage in fatty liver disease Cell death in the liver may be exacerbated by a deficiency in antioxidants, including glutathione
This hasnt been confirmed in humans, but people with a family history of thyroid cancer should be cautious and speak with their healthcare provider before taking the medication